Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

91 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Consore: A Powerful Federated Data Mining Tool Driving a French Research Network to Accelerate Cancer Research.
Guérin J, Nahid A, Tassy L, Deloger M, Bocquet F, Thézenas S, Desandes E, Le Deley MC, Durando X, Jaffré A, Es-Saad I, Crochet H, Le Morvan M, Lion F, Raimbourg J, Khay O, Craynest F, Giro A, Laizet Y, Bertaut A, Joly F, Livartowski A, Heudel P. Guérin J, et al. Among authors: thezenas s. Int J Environ Res Public Health. 2024 Feb 7;21(2):189. doi: 10.3390/ijerph21020189. Int J Environ Res Public Health. 2024. PMID: 38397680 Free PMC article.
Surgical Margins and Adjuvant Therapies in Malignant Phyllodes Tumors of the Breast: A Multicenter Retrospective Study.
Neron M, Sajous C, Thezenas S, Piperno-Neumann S, Reyal F, Laé M, Chakiba C, Michot A, Penel N, Honoré C, Owen C, Bertucci F, Salas S, Saada-Bouzid E, Valentin T, Bompas E, Brahmi M, Ray-Coquard I, Blay JY, Firmin N; French Sarcoma Group (GSF-GETO). Neron M, et al. Among authors: thezenas s. Ann Surg Oncol. 2020 Jun;27(6):1818-1827. doi: 10.1245/s10434-020-08217-y. Epub 2020 Jan 27. Ann Surg Oncol. 2020. PMID: 31989361
Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin With or Without Panitumumab in Patients With Advanced Urothelial Carcinoma: Multicenter, Randomized, French Unicancer GETUG/AFU 19 Study.
Culine S, Fléchon A, Gravis G, Roubaud G, Loriot Y, Joly F, Barthélémy P, Assaf E, Mahammedi H, Beuzeboc P, Houédé N, Rolland F, Guillot A, Gross-Goupil M, Spano JP, Tartas S, Deblock M, Chevreau C, Serrate C, Manduzio H, Habibian M, Thézénas S, Allory Y. Culine S, et al. Among authors: thezenas s. Clin Genitourin Cancer. 2021 Aug;19(4):e216-e222. doi: 10.1016/j.clgc.2021.02.005. Epub 2021 Feb 24. Clin Genitourin Cancer. 2021. PMID: 33753043 Clinical Trial.
Sunitinib Alone or after Nephrectomy in Renal Cancer.
Escudier B, Thezenas S, Méjean A. Escudier B, et al. Among authors: thezenas s. N Engl J Med. 2018 Nov 8;379(19):1878. doi: 10.1056/NEJMc1811532. N Engl J Med. 2018. PMID: 30403947 No abstract available.
Sunitinib Alone or After Nephrectomy for Patients with Metastatic Renal Cell Carcinoma: Is There Still a Role for Cytoreductive Nephrectomy?
Méjean A, Ravaud A, Thezenas S, Chevreau C, Bensalah K, Geoffrois L, Thiery-Vuillemin A, Cormier L, Lang H, Guy L, Gravis G, Rolland F, Linassier C, Lechevallier E, Oudard S, Laguerre B, Gross-Goupil M, Bernhard JC, Colas S, Albiges L, Lebret T, Treluyer JM, Timsit MO, Escudier B. Méjean A, et al. Among authors: thezenas s. Eur Urol. 2021 Oct;80(4):417-424. doi: 10.1016/j.eururo.2021.06.009. Epub 2021 Jun 27. Eur Urol. 2021. PMID: 34187771
Impact of Metastasis Surgery and Alkylating-Agent-Based Chemotherapy on Outcomes of Metastatic Malignant Phyllodes Tumors: A Multicenter Retrospective Study.
Neron M, Sajous C, Thezenas S, Piperno-Neumann S, Reyal F, Laé M, Chakiba C, Penel N, Ryckewaert T, Honoré C, Bertucci F, Monneur A, Salas S, Duffaud F, Saada-Bouzid E, Isambert N, Brahmi M, Ray-Coquard I, Blay JY, Firmin N; French Sarcoma Group (GSF-GETO). Neron M, et al. Among authors: thezenas s. Ann Surg Oncol. 2020 May;27(5):1693-1699. doi: 10.1245/s10434-019-08097-x. Epub 2019 Nov 26. Ann Surg Oncol. 2020. PMID: 31773519
Sorafenib Plus Irinotecan Combination in Patients With RAS-mutated Metastatic Colorectal Cancer Refractory To Standard Combined Chemotherapies: A Multicenter, Randomized Phase 2 Trial (NEXIRI-2/PRODIGE 27).
Samalin E, Fouchardière C, Thézenas S, Boige V, Senellart H, Guimbaud R, Taïeb J, François E, Galais MP, Lièvre A, Seitz JF, Metges JP, Bouché O, Boissière-Michot F, Lopez-Crapez E, Bibeau F, Ho-Pun-Cheung A, Ychou M, Adenis A, Di Fiore F, Mazard T. Samalin E, et al. Among authors: thezenas s. Clin Colorectal Cancer. 2020 Dec;19(4):301-310.e1. doi: 10.1016/j.clcc.2020.04.008. Epub 2020 May 15. Clin Colorectal Cancer. 2020. PMID: 32737004 Clinical Trial.
91 results